Identification and characterization of a subpopulation of CD133+ cancer stem‐like cells derived from SK-UT-1 cells

被引:0
|
作者
Jiuping Gao
Ting Yang
Xu Wang
Yi Zhang
Jing Wang
Beilei Zhang
Dihong Tang
Yanqiong Liu
Ting Gao
Qiuhui Lin
Jun Tang
Jingting Cai
机构
[1] The Affiliated Tumor Hospital of Xiangya Medical School of Central South University,Department of Gynecological Oncology
[2] Xiangya Hospital Central South University,Department of Gynecology and Obstetrics
[3] The second people’s Hospital of Hunan Province,Department of Gynecology and obstetrics
[4] Central Hospital of Yiyang City,Department of Gynecology and obstetrics
[5] The First People’s Hospital of Shaoguang,Department of Gynecology and Obstetrics
来源
关键词
Uterine leiomyosarcoma; Cancer stem cells; Tumorspheres; Drug resistance; CD133;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Biology and clinical implications of CD133+ liver cancer stem cells
    Ma, Stephanie
    EXPERIMENTAL CELL RESEARCH, 2013, 319 (02) : 126 - 132
  • [22] Identification and Characterization of CD133pos Subpopulation Cells From a Human Laryngeal Cancer Cell Line
    Qiu, Hai-ou
    Wang, Huifang
    Che, Na
    Li, Dong
    Mao, Yong
    Zeng, Qiao
    Ge, Rongming
    MEDICAL SCIENCE MONITOR, 2016, 22 : 1146 - 1151
  • [23] CD133+ and CD133- glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles
    Beier, Dagmar
    Hau, Peter
    Proescholdt, Martin
    Lohmeier, Annette
    Wischhusen, Joerg
    Oefner, Peter J.
    Aigner, Ludwig
    Brawanski, Alexander
    Bogdahn, Ulrich
    Beier, Christoph P.
    CANCER RESEARCH, 2007, 67 (09) : 4010 - 4015
  • [24] Biology and plasticity of CD133+ hematopoietic stem cells
    Handgretinger, R
    Gordon, PR
    Leimig, T
    Chen, XH
    Bühring, HJ
    Niethammer, D
    Kuçi, S
    HEMATOPOIETIC STEM CELLS 2002: GENETICS AND FUNCTION, 2003, 996 : 141 - 151
  • [25] CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors
    Shmelkov, Sergey V.
    Butler, Jason M.
    Hooper, Andrea T.
    Hormigo, Adilia
    Kushner, Jared
    Milde, Till
    St. Clair, Ryan
    Baljevic, Muhamed
    White, Ian
    Jin, David K.
    Chadburn, Amy
    Murphy, Andrew J.
    Valenzuela, David M.
    Gale, Nicholas W.
    Thurston, Gavin
    Yancopoulos, George D.
    D'Angelica, Michael
    Kemeny, Nancy
    Lyden, David
    Rafii, Shahin
    JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (06): : 2111 - 2120
  • [26] Cisplatin selects for CD133+ cells in lung cancer cells
    Jiaheng Li
    Mei Jiang
    Xiaoting Zhao
    Ziyu Wang
    Meng Gu
    Weiying Li
    OncologyandTranslationalMedicine, 2020, 6 (01) : 16 - 20
  • [27] Characterization of megakaryocytes progenitor cells differentiated from umbilical cord blood CD133+ and CD133- cells
    Goodarzi, A.
    Pour, M. Aghaeii
    Firozi, A.
    Pourfathaollah, A.
    Tabatabaeian, A.
    Vaeli, S.
    Niroomanesh, S.
    Ebtekar, M.
    Kheirandish, M.
    VOX SANGUINIS, 2006, 91 : 245 - 245
  • [28] Expression of neuronal markers in differentiated marrow stromal cells and CD133+ stem-like cells
    Padovan, CS
    Jahn, K
    Birnbaum, T
    Reich, P
    Sostak, P
    Strupp, M
    Straube, A
    CELL TRANSPLANTATION, 2003, 12 (08) : 839 - 848
  • [29] Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors
    Timmermans, Frank
    Van Hauwermeiren, Filip
    De Smedt, Magda
    Raedt, Robrecht
    Plasschaert, Frank
    De Buyzere, Marc L.
    Gillebert, Thierry C.
    Plum, Jean
    Vandekerckhove, Bart
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (07) : 1572 - 1579
  • [30] Fibronectin extra domain A (EDA) sustains CD133+/CD44+ subpopulation of colorectal cancer cells
    Ou, Juanjuan
    Deng, Jia
    Wei, Xing
    Xie, Ganfeng
    Zhou, Rongbin
    Yu, Liqing
    Liang, Houjie
    STEM CELL RESEARCH, 2013, 11 (02) : 820 - 833